AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026
· ac immune sa
AI Briefing
- AC Immune presents first in vivo images of brain TDP-43 pathology from Phase 1 trial of ACI-19626
- ACI-19626 is a PET tracer used to visualize tau protein in the brain
- The study was presented at the AD/PDTM 2026 conference
Advertisement